Hao Cai

927 total citations
55 papers, 525 citations indexed

About

Hao Cai is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Hao Cai has authored 55 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Physiology and 16 papers in Genetics. Recurrent topics in Hao Cai's work include Peripheral Neuropathies and Disorders (13 papers), Histiocytic Disorders and Treatments (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Hao Cai is often cited by papers focused on Peripheral Neuropathies and Disorders (13 papers), Histiocytic Disorders and Treatments (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Hao Cai collaborates with scholars based in China, United States and United Kingdom. Hao Cai's co-authors include Xinxin Cao, Li J, Daobin Zhou, Qianqian Cai, Lu Zhang, Chen Wang, Minghui Duan, Xufei Huang, Hao Zhao and Xuemin Gao and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Hao Cai

48 papers receiving 520 citations

Peers

Hao Cai
Alessandro Bucalossi Italy
Shokichi Tsukamoto Japan
Edward J. Fudman United States
Adipong Brickshawana United States
N. Horvath United States
Florence Casset‐Semanaz Switzerland
RQ Hintzen Netherlands
Cecilia Isaksson Sweden
Erdwine Klinker Germany
Urania Vourka-Karussis Israel
Alessandro Bucalossi Italy
Hao Cai
Citations per year, relative to Hao Cai Hao Cai (= 1×) peers Alessandro Bucalossi

Countries citing papers authored by Hao Cai

Since Specialization
Citations

This map shows the geographic impact of Hao Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cai more than expected).

Fields of papers citing papers by Hao Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cai. The network helps show where Hao Cai may publish in the future.

Co-authorship network of co-authors of Hao Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Cai. A scholar is included among the top collaborators of Hao Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Cai. Hao Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuezhu, Liping Zuo, Jian Xu, et al.. (2025). Clonal Hematopoietic Mutations in Plasma Cell Disorders: Clinical Subgroups and Shared Pathogenesis. Genomics Proteomics & Bioinformatics. 23(2).
2.
Li, Limin & Hao Cai. (2025). Neutrophil-related immune-inflammatory biomarkers influence the early progression of medial medullary infarction. Frontiers in Neurology. 16. 1528560–1528560.
3.
Wei, Chong, Song Xue, Hao Cai, et al.. (2024). Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma. Frontiers in Immunology. 15. 1365975–1365975. 2 indexed citations
4.
Cai, Hao, et al.. (2024). BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes. Clinical Cancer Research. 31(1). 197–204. 1 indexed citations
5.
Wang, Xuezhu, Xuemin Gao, Junmei Wang, et al.. (2024). Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations. Annals of Hematology. 103(8). 3229–3233. 1 indexed citations
6.
Lang, Min, Lin He, Hao Cai, et al.. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia. 38(4). 803–809. 5 indexed citations
7.
8.
Wang, Wei, Dongmei Zou, Zhe Zhuang, et al.. (2023). Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma. Journal of Oncology. 2023. 1–11. 2 indexed citations
9.
10.
Liu, Ting, Hao Cai, Minghui Duan, et al.. (2022). Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome. Annals of Hematology. 101(9). 1925–1929. 4 indexed citations
11.
Liu, Ting, Hao Cai, Miao Chen, et al.. (2022). Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis. Orphanet Journal of Rare Diseases. 17(1). 39–39. 2 indexed citations
12.
Zhao, Ailin, Minghui Duan, Hao Cai, et al.. (2021). Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis. Leukemia. 36(2). 573–576. 34 indexed citations
13.
Cao, Xinxin, Minghui Duan, Ailin Zhao, et al.. (2021). Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. American Journal of Hematology. 97(2). 203–208. 27 indexed citations
14.
Gao, Xuemin, Yanying Yu, Hao Zhao, et al.. (2021). Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome. Annals of Hematology. 100(11). 2755–2761. 15 indexed citations
15.
Gao, Xuemin, Hao Zhao, Hao Cai, et al.. (2020). A highly heterogeneous mutational pattern in POEMS syndrome. Leukemia. 35(4). 1100–1107. 18 indexed citations
16.
Qiu, Yu, et al.. (2020). Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients. Scientific Reports. 10(1). 12694–12694. 7 indexed citations
17.
18.
Zhao, Hao, Xufei Huang, Xuemin Gao, et al.. (2019). What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?. Leukemia. 33(4). 1023–1029. 36 indexed citations
19.
Cai, Hao, Li J, Minghui Duan, et al.. (2017). Impact of lenalidomide exposure on blood cell collection for autotransplants in persons with POEMS syndrome. Archives of Medical Science. 14(5). 1048–1054. 1 indexed citations
20.
Cao, Xinxin, Li J, Hao Cai, et al.. (2017). Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations. Annals of Hematology. 96(11). 1867–1871. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Bucalossi Breakdown of academic impact, for papers by Shokichi Tsukamoto Breakdown of academic impact, for papers by Edward J. Fudman Breakdown of academic impact, for papers by Adipong Brickshawana Breakdown of academic impact, for papers by N. Horvath Breakdown of academic impact, for papers by Florence Casset‐Semanaz Breakdown of academic impact, for papers by RQ Hintzen Breakdown of academic impact, for papers by Cecilia Isaksson Breakdown of academic impact, for papers by Erdwine Klinker Breakdown of academic impact, for papers by Urania Vourka-Karussis
Rankless by CCL
2026